IL6 and listeriosis: Considering the reduced Th17 immunocompetency as the main risk factor of listeriosis, biomarkers of poor prognosis, such as high sensitivity to hypervirulent Listeria clones, low IL-17A/IL-6 ratios, and anti-GAPDH1–22 antibodies should assist in reducing listeriosis incidence.